Test agent for visceral obesity and use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 10, 2013
Grant Date -
Mar 15, 2012
app pub date -
May 13, 2010
filing date -
May 13, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed are: a method for detecting (diagnosing) visceral obesity in a subject; a test agent useful for the method; a method for searching for a substance that can be used as an active ingredient for ameliorating visceral obesity; and an ameliorating agent for visceral obesity or a medicinal agent for preventing a metabolic disease developed as a result of the progression of visceral obesity. As the test agent, a polynucleotide which comprises at least 15 nucleotides and can hybridize with a nucleotide sequence for coiled-coil domain containing protein 3 (CCDC3) gene or a nucleotide sequence complementary to the nucleotide sequence under stringent conditions or an antibody capable of recognizing CCDC3 protein is used.
First Claim
Other Claims data not available
Family
International Classification(s)
- 2010 Application Filing Year
- C40B Class
- 687 Applications Filed
- 134 Patents Issued To-Date
- 19.51 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Mar 10, 2025 |
